Bulk Drug Substance Logistics – Primary Packaging

It has become standard procedure to geographically detach the processing of biopharmaceutical substances from production of the final medicinal drug product: Large batches of the active ingredient are being manufactured at one location; the ingredient is then divided into many smaller frozen units that are shipped to various sites around the globe for the final processing.

Due to regulation, the life impacting nature of drugs, and their monetary value (especially in larger volumes), manufacturers are understandably cautious about adopting new technologies in sensitive operations. There are currently many options of primary packages on how to transport the drug substance from A to B.

Click here to read the complete Challenges In Bulk Drug Substance Logistics EBook